CTXR 8-K 2026-08-14

Citius Pharmaceuticals, Inc. (CTXR) 8-K dated 2026-08-14 — accession 0001213900-26-090181. This URL is the filing, not the CTXR hub.

Citius Pharmaceuticals, Inc. (CTXR) is a biotechnology company listed on US.

Citius Pharmaceuticals, Inc. filed a 8-K on 2026-08-14. Accession 0001213900-26-090181.

Cached items: 2.02, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported CTXR revenue for 2026-06-30 was $7.1M. Net income was -$49.4M. Revenue was up 26.6% from 2026-03-31 to 2026-06-30. CTXR currently screens at market cap $13.4M.

Not investment advice. The CTXR SEC hub lists recent forms. The stock page is the research view.